Literature DB >> 15306171

Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice.

Kuang-Yuh Chyu1, Odette S Reyes, Xiaoning Zhao, Juliana Yano, Paul Dimayuga, Jan Nilsson, Bojan Cercek, Prediman K Shah.   

Abstract

BACKGROUND: Immunization of animals with LDL reduces atherosclerosis. However, whether the timing of immunization affects its efficacy is not known. In this study, we evaluated the influence of timing of immunization on the athero-protective effects of LDL immunization in apo E (-/-) mice. METHODS AND
RESULTS: Hypercholesterolemic apo E (-/-) mice were immunized with native LDL (nLDL) at age of 6-7 weeks old or at 20 weeks old. Compared to adjuvant group, mice that were immunized at the age of 6-7 weeks developed significantly smaller aortic sinus plaques with reduced gelatinolytic activity and increased collagen content. This was associated with an increase of oxidized LDL (oxLDL) antibody titer and a marked decrease in splenic IL-4 mRNA expression. Immunization at 20 weeks of age also increased oxLDL antibody titer but did not reduce plaque size, gelatinolytic activity or collagen content but resulted in a modest decrease in macrophage infiltration. Late immunization did not alter splenic IL-4 mRNA expression.
CONCLUSIONS: Our findings demonstrate that, only early nLDL immunization modulates humoral and cellular immune responses and affects plaques size and composition in apo E (-/-) mice, indicating the critical importance of timing of immunization for its antiatherogenic efficacy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306171     DOI: 10.1016/j.atherosclerosis.2004.04.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Vaccine against arteriosclerosis: an update.

Authors:  Kuang-Yuh Chyu; Paul C Dimayuga; Prediman K Shah
Journal:  Ther Adv Vaccines       Date:  2017-02-01

Review 2.  The role of the vascular dendritic cell network in atherosclerosis.

Authors:  Noah Alberts-Grill; Timothy L Denning; Amir Rezvan; Hanjoong Jo
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-03       Impact factor: 4.249

3.  CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.

Authors:  Kuang-Yuh Chyu; Xiaoning Zhao; Paul C Dimayuga; Jianchang Zhou; Xiaojun Li; Juliana Yano; Wai Man Lio; Lai Fan Chan; Jonathan Kirzner; Portia Trinidad; Bojan Cercek; Prediman K Shah
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

Review 4.  Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects.

Authors:  Dimitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Front Physiol       Date:  2014-05-27       Impact factor: 4.566

5.  Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.

Authors:  Paul C Dimayuga; Xiaoning Zhao; Juliana Yano; Wai Man Lio; Jianchang Zhou; Peter M Mihailovic; Bojan Cercek; Prediman K Shah; Kuang-Yuh Chyu
Journal:  J Am Heart Assoc       Date:  2017-07-15       Impact factor: 5.501

Review 6.  Vaccination in Atherosclerosis.

Authors:  Felix Sebastian Nettersheim; Lauren De Vore; Holger Winkels
Journal:  Cells       Date:  2020-11-30       Impact factor: 6.600

Review 7.  Immunization for atherosclerosis.

Authors:  Kuang-Yuh Chyu; Jan Nilsson; Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.967

8.  Cholesterol lowering modulates T cell function in vivo and in vitro.

Authors:  Kuang-Yuh Chyu; Wai Man Lio; Paul C Dimayuga; Jianchang Zhou; Xiaoning Zhao; Juliana Yano; Portia Trinidad; Tomoyuki Honjo; Bojan Cercek; Prediman K Shah
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

9.  CD4+/CD8+ ratio positively correlates with coronary plaque instability in unstable angina pectoris patients but fails to predict major adverse cardiovascular events.

Authors:  Dayang Chai; Xiangquan Kong; Shu Lu; Junjie Zhang
Journal:  Ther Adv Chronic Dis       Date:  2020-05-18       Impact factor: 5.091

10.  Modulating Autoimmunity against LDL: Development of a Vaccine against Atherosclerosis.

Authors:  Timoteo Marchini; Tijani Abogunloko; Dennis Wolf
Journal:  Hamostaseologie       Date:  2021-12-23       Impact factor: 1.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.